In May of 2009, StemCell Pharma, Inc. (SCPI) will organize an international commission for the examination of Edi Leanca, a Romanian boy born blind and diagnosed with Leber’s congenital amaurosis (LCA), the most severe form of Retinitis pigmentosa (RP). They say he regained his sight after receiving stem cell implants. The technique used on Edi Leanca is a proprietary technique owned by SCPI. The examination will take place in Bucharest, Romania by a commission made up of retinal experts with representatives from Romania, the European community, Russia and the USA.
[Via WSJ]
Popularity: 2% [?]
